Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a suspicious growth or mass near the ovaries that doctors believe may be early-stage ovarian cancer.
- People who are healthy enough, both medically and physically, to undergo a sentinel lymph node biopsy procedure and a full lymph node removal surgery.
Who may not be able to join:
- People whose ovarian mass is considered unlikely to be early-stage ovarian cancer.
- People who have medical or physical conditions that make comprehensive staging surgery unsafe or unsuitable for them.
- People whose ovarian cancer has spread to other parts of the body, or who have a second, separate cancer occurring at a different time (confirm with trial site).
- People who have had ovarian cancer that has come back after previous treatment.
- People where surgery or pre-surgical assessment shows the cancer has already reached an advanced stage (known medically as FIGO Stage III or IV).
- People who are receiving chemotherapy or other treatment before surgery to shrink the cancer first (sometimes called neoadjuvant treatment).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +90 532 687 10 51
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of sentinel lymph node biopsy in highly suspicious adnexal masses for early-stage ovarian cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.